Ana Vergés

Cardióloga, Internista, ecocardiografista, Dominicana, madre de Ethan y Lia, apasionada por la vida. Amante del corazón.

[American College of Cardiology @ACCinTouch]

🆕 2026 AHA/ACC/ADA/ASN Guideline for Cardiovascular-Kidney-Metabolic Syndrome provides recommendations for the prevention, detection, evaluation, & management of interconnected CV, kidney, & metabolic disease.

More in #JACC 👉 https://t.co/cwdsA0ED9U #ClinicalGuidelines

[clara saldarriaga @clara_clarais]

Join us for this outstanding educational program on optimizing heart failure treatment, featuring a practical and innovative approach to improving patient care. #HeartFailure #Cardiology @Medscape @MedscapeES

[JAMA Cardiology @JAMACardio]

💬 Editorial: Among patients with #HFrEF in the Veterans Health Administration, fewer than 1 in 6 achieved quadruple therapy and the median time to initiation exceeded 6 months.

https://t.co/WDlGfreTH5

[Lucrecia M. Burgos, MD @lucreciamburgos]

🚨 IMPEDANCE-HFpEF — #ACC26
One of the most anticipated trials delivers striking results
🔑 Noninvasive lung fluid monitoring:
• ↓ 81% HF hospitalizations
• ↓ 65% all-cause mortality
• Earlier and more frequent treatment adjustments
🧠 Detecting congestion before symptoms may change how we manage HFpEF

[Maxima Mendez MD. FSIAC,FACC. @MaximaMendez15]

Dominican Republic contributing a grain of sand in global research @ACCinTouch
Congress 2025 @JACCJournals

Thanks to my research team !

@society_eas
@atherosociety
#ACC25 #ACCPrev

Links bellow
https://t.co/AlxzSYQbDr

https://t.co/Qt6olP3Eg8

https://t.co/9wLmx5j30B

[Women As One @WomenAs1]

Congratulations to our co-founder @Drroxmehran on becoming President of @ACCinTouch!

This milestone reflects her leadership, impact and commitment to advancing equity. She opens doors, elevates voices, & reshapes what's possible for women in cardiology!

#ACC26

[Alfonso Valle @ValleAlfonso]

🟢Kerendia™ (finerenone) approved in 🇪🇺
is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate statistically significant and clinically meaningful cardiovascular benefits in a Phase III study in patients with HF with LVEF ≥40%

[Maxima Mendez MD. FSIAC,FACC. @MaximaMendez15]

Beyond the sessions,
this is where leadership connects.

⭐ #ACC26

Sharing perspectives with researchers and leaders who have shaped modern cardiovascular prevention.

Because advancing the field requires more than data.
It requires collaboration.

@ACCinTouch @JACCJournals

[Bernardita González, MD @Bernilina]

Mañana! 👀
No se lo pierdan! 🙌🏻

@cifacah @Sochicaroficial @Toraxchile @sodocardio1 @SIAC_cardio

[Ana Vergés @VergesAna]

Mañana nuestro webinar conjunto SODOCARDIO y CIFACAH: comorbilidades en IC. Imperdible!!

https://t.co/XUrq4JwyjB

[Bernardita González, MD @Bernilina]

Atención!
Próximo martes 11 de Noviembre!
Nuevo webinar @cifacah , esta vez junto a @sodocardio1

No se lo pierdan! 🫀🙌🏻

[EJHF Editor-in-Chief @EJHFEiC]

🗞️ Future development of arrhythmogenic risk scores in patients with #HeartFailure & inherited dilated cardiomyopathy.
A scientific statement of the #HFA of @escardio

@ESC_Journals @GiuseppeGalati_

@AmrAbdin10 @HanCardiomd
@HFA_President

https://t.co/BF7LQEPOrP

[Women As One @WomenAs1]

Ready to grow your network? 🩺

Join The Pulse, complete your profile, explore Groups and the Live Feed, and connect with thousands of women in cardiology worldwide.

Get started: https://t.co/U3BFL66pIX

#CardioTwitter #WIC @Drroxmehran @drmalissawood

[Ana Vergés @VergesAna]

@clara_clarais @secardiologia @sccccardio So proud of you!! Together we do better!!

[Novi Yanti Sari @slumberbell]

Maternal #HeartFailure, lessons from Sweden🫀:
A nationwide, population-based study (2000–2019) involving >2 million deliveries found:
📍66% ⬆️ in maternal HF incidence
📍0.34 cases per 1,000 deliveries
📍~50% with associated cardiac disease
📍some risk factors: 🤰maternal age > 35, #hypertension, multiple gestation, & hypertensive disorders of pregnancy

👉While rising comorbidities explain part of this trend, the growing burden of maternal #HF remains a clinical concern.
👉Early recognition, prevention, & coordinated care are essential

More in @JACCJournals #JACCHF: https://t.co/ZRK6HsgvDg

#CardioOB #CardioObstetrics @CardioOb #ACCCardioOB

[Edgardo Alania @Ed_Alania]

🔴 The Key Role of Diagnostic Imaging in Early HFpEF @JACCJournals #Cardiology #CardioEd #Echofirst

[Maxima Mendez MD. FSIAC,FACC. @MaximaMendez15]

#NewProfilePic

[Maxima Mendez MD. FSIAC,FACC. @MaximaMendez15]

New chapter published in the book 📘

"Pathogenesis of subclinical atherosclerosis" - SIAC 2026.

We explore how inflammation, endothelial dysfunction and the NLRP3 inflammasome drive atherosclerotic progression from early stages.

Méndez Castillo M, Alonso R, Salgueiro J.

[Novi Yanti Sari @slumberbell]

From the latest 2025 #ESCGuidelines for the management of #CVdisease in pregnancy:

💊Choices of medications use during Pregnancy & during lactation+breastfeeding

Full paper @ehj_ed #EHJ: https://t.co/sPjdY7saWh

@escardio @ESC_Journals #ESCCongress
@CardioOb #CardioObstetrics

[Ezequiel Zaidel @EzequielZaidel]

📍
#ChagasDisease
At last a well designed randomized clinical trial!
After these results, would you change from enalapril to SacVal? (Remember these are poor people 7million mainly in rural LatAm and cost of SacVal is much higher than ENL)
Disclosure: I would!